Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
14281006 205164 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 205164 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281026 167408 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 167408 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281025 205058 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 205058 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1711 77 12 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
5310983 77 12 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
CHEMBL336208 77 12 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
3352 2339 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5280879 2339 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5863 2339 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
CHEMBL509456 2339 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
1756 459 8 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5310954 459 8 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL336292 459 8 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5492386 204760 3 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 204760 3 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
135434015 202226 10 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 202226 10 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
14281041 205255 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91359 205255 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 105651 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 105651 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135409400 203193 72 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
CHEMBL760 203193 72 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
15005606 204831 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 204831 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281012 105529 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL313282 105529 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
14281011 205088 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 205088 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
15005605 204832 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 204832 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005586 106441 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 106441 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 205177 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 205177 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281001 205418 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 205418 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281010 205271 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 205271 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281011 205088 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 205088 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
440317 21548 15 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
CHEMBL131890 21548 15 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
15005591 204780 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88377 204780 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005580 205046 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 205046 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281024 204838 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 204838 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281020 106057 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314093 106057 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 105651 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 105651 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281023 205200 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91044 205200 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005608 205226 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 205226 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281005 205630 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 205630 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005569 110971 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
CHEMBL327580 110971 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
5492386 204760 3 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 204760 3 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281004 205254 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 205254 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
15005588 205419 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 205419 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005581 205188 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90958 205188 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280996 205313 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL91634 205313 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
14280992 204802 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88525 204802 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005576 204788 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 204788 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005584 205052 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 205052 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005574 205293 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 205293 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
5487281 204812 13 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 204812 13 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
14281001 205418 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 205418 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281015 111088 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 111088 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005605 204832 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 204832 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
10016898 205120 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90566 205120 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005600 204757 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88224 204757 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
136677322 3244 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
1739 3244 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
656725 3244 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
CHEMBL1160031 3244 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
14281027 204971 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL89679 204971 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005586 106441 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 106441 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005573 205251 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL91340 205251 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
15005599 204828 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88697 204828 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281000 204967 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
CHEMBL89660 204967 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
15005601 111305 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL328755 111305 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005566 204858 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 204858 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005603 163561 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 163561 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 112141 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 112141 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005571 205242 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91295 205242 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1713 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5957 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
91 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14249 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
DB00171 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
14281034 110939 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL327374 110939 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005572 163262 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 163262 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
15005566 204858 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 204858 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005564 164872 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 164872 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005578 205302 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 205302 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
5487281 204812 13 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 204812 13 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
15005594 205140 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL90677 205140 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281005 205630 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 205630 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005584 205052 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 205052 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
9999105 204755 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88218 204755 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
135973538 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
1728 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
2966 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
4261196 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
5361 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
CHEMBL265502 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
DB04786 3654 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
15005608 205226 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 205226 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281003 205233 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
CHEMBL91259 205233 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
15005603 163561 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 163561 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005598 204834 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88730 204834 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005602 205212 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91127 205212 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135434015 202226 10 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 202226 10 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
15005578 205302 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 205302 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
14281031 205358 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91899 205358 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005606 204831 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 204831 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281026 167408 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 167408 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281016 205258 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 205258 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281018 205433 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL92363 205433 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281036 204829 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
CHEMBL88698 204829 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
15005592 205040 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 205040 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005572 163262 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 163262 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
44323790 204843 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 204843 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281024 204838 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 204838 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005574 205293 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 205293 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005592 205040 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 205040 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005585 205287 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 205287 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 205177 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 205177 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281006 205164 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 205164 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
134687118 192181 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5179763 192181 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5221347 192181 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
14281008 204869 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88955 204869 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005588 205419 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 205419 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 112141 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 112141 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005564 164872 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 164872 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005604 204764 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88265 204764 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005590 204850 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL88835 204850 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
10017729 204737 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 204737 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1712 285 64 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
6022 285 64 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14830 285 64 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
135838395 105672 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
CHEMBL313609 105672 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
14281016 205258 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 205258 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281010 205271 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 205271 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005580 205046 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 205046 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281033 112306 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330677 112306 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281004 205254 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 205254 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
14281025 205058 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 205058 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005576 204788 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 204788 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1755 286 16 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5310996 286 16 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL335206 286 16 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
10017729 204737 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 204737 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281035 204998 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL89876 204998 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005567 205347 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91837 205347 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281015 111088 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 111088 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005585 205287 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 205287 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005577 204732 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 204732 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14280999 204784 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL88395 204784 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
15005570 205304 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
CHEMBL91579 205304 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
14280998 205349 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91843 205349 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005583 205396 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92158 205396 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
44323790 204843 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 204843 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
15005577 204732 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 204732 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
44443919 93980 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL251024 93980 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
23649184 189742 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5176593 189742 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
1776 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5006 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
9854012 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL334966 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
DB06441 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
44443921 168189 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL437204 168189 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
1776 775 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
5006 775 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
9854012 775 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
CHEMBL334966 775 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
DB06441 775 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
44555026 111450 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 111450 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11526078 90876 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 90876 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68910943 91669 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 91669 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
44443917 93946 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250832 93946 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
24751997 62499 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 62499 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68550683 190463 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5187308 190463 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
45485968 196070 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 196070 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752128 62474 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 62474 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269461 194520 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 194520 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752129 62481 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 62481 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457371 10264 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
CHEMBL1162189 10264 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
10098947 10242 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162163 10242 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
11786496 10253 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162176 10253 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
53233471 62508 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 62508 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911088 90850 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 90850 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11504760 90860 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 90860 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
53233471 62508 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 62508 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 62495 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 62495 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485965 195097 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 195097 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 195845 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 195845 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 193219 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 193219 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751300 62483 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 62483 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 62495 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 62495 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751575 62498 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 62498 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 62516 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 62516 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650877 199514 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60353 199514 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45272846 193981 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 193981 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801416 10277 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162205 10277 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
45268630 194414 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 194414 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457278 10246 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162167 10246 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
45485930 195518 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 195518 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485858 195646 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 195646 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 195870 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 195870 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751438 62473 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 62473 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15650865 100314 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292978 100314 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650880 100567 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL294588 100567 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650878 199533 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60362 199533 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452737 96443 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL265707 96443 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457411 10270 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162197 10270 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
16739157 10255 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162179 10255 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
44610522 111441 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288125 111441 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11712235 90890 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 90890 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11620159 91670 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 91670 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
68916097 90862 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 90862 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
45485943 195441 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 195441 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485960 195450 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 195450 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 195767 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 195767 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 195773 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 195773 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485900 195840 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 195840 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752269 62472 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 62472 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
131257 201083 3 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62094 201083 3 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452879 160742 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL412171 160742 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45269473 194666 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 194666 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485896 195104 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 195104 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485934 195301 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 195301 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485941 195346 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 195346 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751996 62521 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 62521 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650899 201278 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
CHEMBL63016 201278 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
71740705 90863 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 90863 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45270300 193726 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 193726 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650869 201449 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64144 201449 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650870 201452 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64149 201452 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45270321 193847 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 193847 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
11706300 90857 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 90857 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 90888 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 90888 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45485969 195092 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 195092 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485902 195749 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 195749 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 195878 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 195878 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 195891 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 195891 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752560 62475 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 62475 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485853 195677 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 195677 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269438 194327 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 194327 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24968874 91667 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 91667 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
11273179 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
1770 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
CHEMBL1162175 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
DB05553 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
11273179 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
1770 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
CHEMBL1162175 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
DB05553 3249 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
90644282 111438 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 111438 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
16739124 10263 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162188 10263 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485966 195168 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 195168 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 195818 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 195818 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485952 195876 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 195876 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271155 193967 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 193967 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751579 62490 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 62490 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457276 10245 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162166 10245 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
44457392 10267 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
CHEMBL1162194 10267 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
44610468 111443 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 111443 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
54586076 62225 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 62225 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
73345971 90868 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 90868 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
45485937 195571 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 195571 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485859 195784 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 195784 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751581 62189 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 62189 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54586076 62225 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 62225 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45269484 193992 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 193992 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45271145 193260 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 193260 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
69224603 91654 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 91654 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
15983052 91655 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 91655 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
24752130 62477 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 62477 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 62509 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 62509 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
71740819 90864 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 90864 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485857 195801 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 195801 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485938 195849 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 195849 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193180 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193180 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54585885 62501 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 62501 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457274 10244 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162165 10244 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
44554515 111439 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
69224555 91660 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 91660 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68556549 111437 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 111437 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11503160 90882 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 90882 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
24752131 62512 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 62512 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269454 194444 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 194444 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 194999 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 194999 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650861 201003 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61623 201003 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15983175 91659 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 91659 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
45485945 195402 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 195402 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485947 195869 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 195869 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272055 193224 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 193224 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751995 62489 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 62489 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751708 62517 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 62517 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650881 201453 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64153 201453 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453107 154768 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403010 154768 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272035 193419 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 193419 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11570029 90875 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 90875 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
16739091 10251 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162172 10251 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
24752557 62476 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 62476 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485916 195226 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 195226 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
54584960 62525 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 62525 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272842 193951 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 193951 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739125 10252 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162173 10252 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
68916926 139161 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 139161 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
11684912 90870 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 90870 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11561528 90892 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 90892 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68842714 90893 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 90893 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485911 195831 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 195831 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751572 62226 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 62226 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
44453110 154769 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403011 154769 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
15983053 91658 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 91658 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
69224054 91665 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 91665 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
45485961 195330 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 195330 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750723 62484 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 62484 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485954 195877 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 195877 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270322 193114 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 193114 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24750719 62524 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 62524 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24799317 10239 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162160 10239 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
16739092 10250 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162171 10250 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
44457422 10273 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
CHEMBL1162200 10273 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
68918061 90851 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 90851 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11699088 90856 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 90856 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752711 62505 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 62505 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45271154 193997 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 193997 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25022501 94639 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255349 94639 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452925 165871 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL427723 165871 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452982 94680 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255553 94680 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
23649325 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68911289 90880 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 90880 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 90880 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
23649325 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
11993787 91666 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 91666 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
44452926 96967 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL269934 96967 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273798 194015 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 194015 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913927 90887 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 90887 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11532836 90897 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 90897 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68554177 190687 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5190691 190687 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
24751574 62224 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 62224 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751999 62488 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 62488 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485892 195359 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 195359 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 195542 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 195542 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485848 195711 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 195711 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485890 195807 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 195807 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485967 195868 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 195868 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751574 62224 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 62224 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
24751999 62488 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 62488 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650866 199639 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60422 199639 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45273812 194083 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 194083 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44610518 111440 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288124 111440 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
90644279 111449 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
CHEMBL3288133 111449 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
45485963 195416 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 195416 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752561 62502 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 62502 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752421 62511 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 62511 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44452951 97305 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL271643 97305 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485939 195474 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 195474 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 196067 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 196067 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457290 10247 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162168 10247 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485959 195533 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 195533 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
23642329 62491 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 62491 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270323 193577 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 193577 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650882 201256 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62928 201256 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271984 193418 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 193418 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273789 194233 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 194233 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45267750 194253 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 194253 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739158 10243 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162164 10243 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
15983055 91656 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 91656 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
54580044 62526 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 62526 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44453131 154925 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403928 154925 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
11503687 90898 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 90898 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
2746550 62480 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 62480 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485919 195115 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 195115 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485852 195748 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 195748 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485861 195788 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 195788 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485909 195836 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 195836 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270295 193103 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 193103 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579996 62496 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 62496 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 62515 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 62515 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650875 201518 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64383 201518 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742794 201604 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64734 201604 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457324 10254 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162178 10254 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
11561748 91668 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 91668 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
45268594 193890 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 193890 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801573 10268 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162195 10268 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
24752422 62479 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 62479 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11641496 90855 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 90855 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68911008 90886 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 90886 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15983546 91673 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 91673 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
24752271 62503 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 62503 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 10237 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 10237 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45273819 193483 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 193483 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270314 193475 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 193475 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11569565 90889 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 90889 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
1746 2011 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
44457307 2011 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
CHEMBL1162174 2011 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
24752270 62504 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 62504 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485888 195286 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 195286 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44304081 165166 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
CHEMBL424596 165166 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
16739093 10257 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
CHEMBL1162182 10257 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
23649325 536 47 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
7360 536 47 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
CHEMBL2419490 536 47 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
45485862 195802 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 195802 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485905 195844 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 195844 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269465 194580 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 194580 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11677907 90852 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 90852 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
45485956 195889 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 195889 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740352 90894 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 90894 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485894 195777 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 195777 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54580995 62487 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 62487 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983672 91663 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 91663 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
11663657 90871 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 90871 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11656053 90878 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 90878 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68914580 90881 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 90881 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751712 62500 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 62500 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44452947 154648 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402401 154648 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485863 195789 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 195789 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270294 193658 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 193658 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54584163 62227 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 62227 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
11519648 90869 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 90869 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
1765 3757 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
4184 3757 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
9871419 3757 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
CHEMBL398435 3757 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
DB08816 3757 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
45485962 195354 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 195354 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193180 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193180 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 194426 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 194426 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44452898 94640 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255350 94640 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485935 195374 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 195374 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 195890 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 195890 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273782 193836 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 193836 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650862 199744 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60481 199744 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650876 200689 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61062 200689 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742793 201259 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62939 201259 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650873 201703 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL65466 201703 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650872 201855 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66594 201855 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11595497 201457 4 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64162 201457 4 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
16739094 10259 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162184 10259 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485889 195313 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 195313 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268642 193945 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 193945 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650856 100555 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL294535 100555 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650888 201864 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
CHEMBL66647 201864 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
44610519 111442 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 111442 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
24751850 62492 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 62492 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272861 193810 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 193810 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650874 201780 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66027 201780 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650867 101819 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
CHEMBL303366 101819 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
15650864 199634 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60420 199634 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453009 154677 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402592 154677 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485851 195756 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 195756 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272036 193913 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 193913 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650858 198912 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59922 198912 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
24752419 62506 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 62506 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751576 62520 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 62520 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270296 193659 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 193659 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24799834 10265 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162190 10265 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
122192512 123292 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
CHEMBL3623467 123292 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
24751710 62518 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 62518 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583974 62497 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 62497 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457292 10248 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162169 10248 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
11497605 90872 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 90872 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11691323 90879 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 90879 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650857 198745 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
CHEMBL59822 198745 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
44452736 95718 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL260602 95718 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457401 10269 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162196 10269 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
44453109 154716 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402800 154716 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485957 195880 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 195880 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 196068 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 196068 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750874 62513 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 62513 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
45485864 195311 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 195311 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453032 97394 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272113 97394 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
54579997 62519 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 62519 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650871 201632 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64863 201632 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
24752558 90865 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 90865 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45485915 195846 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 195846 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 195837 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 195837 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453132 97575 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272975 97575 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24801414 10240 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162161 10240 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485901 195843 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 195843 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457251 10238 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162159 10238 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
16739123 10260 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162185 10260 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
11627571 90859 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 90859 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485908 195835 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 195835 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740353 90895 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 90895 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485942 195850 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 195850 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650887 201555 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
CHEMBL64555 201555 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
15982393 90891 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 90891 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45272869 193811 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 193811 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579995 62482 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 62482 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 10237 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 10237 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45485932 195482 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 195482 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267721 195047 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 195047 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44608149 111445 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 111445 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68911155 90885 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 90885 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24799835 10262 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162187 10262 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45272054 193223 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 193223 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
69224988 91664 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 91664 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
68911027 90854 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 90854 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
44452952 154529 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL401780 154529 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24750561 62522 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 62522 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
45267728 194532 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 194532 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650859 101735 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL302875 101735 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68556579 111444 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 111444 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
15650886 100170 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292047 100170 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
44452878 96630 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL267283 96630 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273811 194822 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 194822 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485933 195848 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 195848 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271092 194770 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 194770 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485886 195806 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 195806 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485950 195872 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 195872 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750876 62510 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 62510 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45273818 193179 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 193179 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580993 62470 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 62470 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15983670 91657 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 91657 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
45485903 195841 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 195841 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650860 201157 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62470 201157 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457294 10249 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
CHEMBL1162170 10249 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
45485914 195838 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 195838 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44452921 94819 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL256251 94819 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
2746549 62223 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 62223 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
2746549 62223 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 62223 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485946 196098 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 196098 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
68913220 90853 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 90853 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
45485953 195888 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 195888 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650898 201162 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62500 201162 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11569565 90889 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 90889 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
24751577 62514 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 62514 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485856 195798 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 195798 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650868 198889 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59911 198889 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68911120 91662 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 91662 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
45272902 194042 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 194042 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485898 195500 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 195500 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
73294137 91661 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 91661 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
45485922 195392 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 195392 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267707 194295 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 194295 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 193602 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 193602 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457338 10256 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
CHEMBL1162181 10256 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
25165435 111448 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 111448 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
54581027 62523 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 62523 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269483 193125 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 193125 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272881 193192 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 193192 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 194681 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 194681 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 193640 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 193640 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485921 195343 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 195343 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 195847 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 195847 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273820 193181 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 193181 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913141 90883 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 90883 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
45485918 195299 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 195299 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269472 194665 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 194665 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485849 195753 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 195753 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
90644280 111447 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 111447 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
68911205 91671 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 91671 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
15650883 162722 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL418660 162722 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44241562 194758 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
CHEMBL562982 194758 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
45485936 195378 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 195378 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 195463 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 195463 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829943 194240 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 194240 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268619 193834 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 193834 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15983301 90884 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 90884 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
44457262 10241 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162162 10241 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
24750557 62485 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 62485 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11697626 91672 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 91672 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
24751851 62494 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 62494 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
4742792 198944 9 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL59941 198944 9 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271128 193259 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 193259 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580185 62230 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 62230 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485931 195190 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 195190 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54585098 62229 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 62229 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457247 10236 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 10236 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485855 195797 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 195797 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485917 195822 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 195822 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457247 10236 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 10236 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
11627317 90861 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 90861 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650897 199131 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60083 199131 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11706351 90873 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 90873 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45142449 194656 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 194656 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650863 199346 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60240 199346 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
90644281 111446 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 111446 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
45485958 195447 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 195447 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 195842 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 195842 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485860 195785 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 195785 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268641 193170 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 193170 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752559 62478 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 62478 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751297 62486 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 62486 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 62493 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 62493 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11699570 90874 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 90874 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
54580994 62471 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 62471 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24829780 194791 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 194791 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68910943 91669 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 91669 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11684524 90877 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 90877 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751017 90896 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 90896 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
44452977 95117 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL257651 95117 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272880 193812 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 193812 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44583582 3155 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
5904 3155 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
59448166 3155 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL1207916 3155 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL455536 3155 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
44583582 3155 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
5904 3155 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
59448166 3155 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL1207916 3155 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL455536 3155 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
1765 3757 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 3757 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 3757 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 3757 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 3757 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1776 775 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
5006 775 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
9854012 775 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
CHEMBL334966 775 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
DB06441 775 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
10340 1100 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
137553172 1100 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
1764 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
189762 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
CHEMBL606240 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
1732 446 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
25243905 446 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
16741348 746 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
1766 746 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
139031067 1092 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
6148 1092 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
73755176 1092 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
3384 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
3384 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
5311009 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
5311009 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
CHEMBL1160359 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
CHEMBL1160359 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
1776 775 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
5006 775 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
9854012 775 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
CHEMBL334966 775 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
DB06441 775 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
121990 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1710 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1763 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
CHEMBL435402 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1755 286 16 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
5310996 286 16 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
CHEMBL335206 286 16 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
1776 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
5006 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
9854012 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
CHEMBL334966 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
DB06441 775 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
10405534 3217 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1771 3217 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
CHEMBL3526431 3217 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1769 2012 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
91827342 2012 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
16681707 748 4 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
1767 748 4 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
CHEMBL2172275 748 4 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
11273179 3249 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1770 3249 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
CHEMBL1162175 3249 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
DB05553 3249 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1765 3757 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
4184 3757 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
9871419 3757 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
CHEMBL398435 3757 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
DB08816 3757 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
1776 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5006 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
9854012 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL334966 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
DB06441 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
1776 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
5006 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
9854012 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
CHEMBL334966 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
DB06441 775 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
10557443 10129 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
CHEMBL1160364 10129 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
66575818 113570 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 113570 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 111439 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
49764561 189543 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5173489 189543 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
49764180 189943 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5179719 189943 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
46931928 190241 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5184268 190241 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763085 190839 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5192953 190839 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
49764183 190995 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5195237 190995 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763087 191517 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5203416 191517 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
15983053 91658 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 91658 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
66854978 190688 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5190693 190688 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
87180479 191762 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207212 191762 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
1765 3757 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
4184 3757 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
9871419 3757 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
CHEMBL398435 3757 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
DB08816 3757 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
118711090 113352 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 113352 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67460312 113122 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322621 113122 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711072 113334 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 113334 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711074 113336 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 113336 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711077 113339 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 113339 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711079 113341 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 113341 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711087 113349 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 113349 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711091 113353 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 113353 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576450 113396 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 113396 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54581027 62523 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 62523 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580044 62526 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 62526 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600063 126141 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
CHEMBL3652613 126141 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
118711172 113394 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 113394 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127039360 136617 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
127040666 136617 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745863 136617 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747870 136617 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
25165435 111448 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 111448 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
44608149 111445 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 111445 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711093 113355 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 113355 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 536 47 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 536 47 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 536 47 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24968874 91667 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 91667 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
118711190 113418 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113418 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 113419 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113419 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113420 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113420 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
67460624 113134 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322632 113134 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607689 103735 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 103735 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983055 91656 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 91656 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
24751997 62499 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 62499 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL54256 193279 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 664 7 2 14 1.5 CS(=O)(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(S(C)(=O)=O)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711084 113346 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 113346 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711086 113348 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 113348 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711088 113350 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 113350 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 113399 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 113399 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 113406 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113406 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
11684524 90877 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 90877 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11561528 90892 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 90892 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752129 62481 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 62481 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751577 62514 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 62514 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968628 164578 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227647 164578 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145971167 164600 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4227969 164600 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
145967502 164637 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228684 164637 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
44610519 111442 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 111442 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68556579 111444 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 111444 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711089 113351 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 113351 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127038951 136626 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240906 136626 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746312 136626 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747879 136626 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
71607634 103728 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 103728 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711083 113345 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 113345 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
90644280 111447 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 111447 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
118711091 113353 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 113353 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 113410 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 113410 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
68600322 126139 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652611 126139 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
15983175 91659 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 91659 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
118711180 113403 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 113403 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576220 113421 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11684912 90870 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 90870 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706351 90873 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 90873 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911120 91662 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 91662 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
118711179 113402 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 113402 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983175 91659 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 91659 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
24751575 62498 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 62498 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
22185065 164526 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226930 164526 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71740352 90894 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 90894 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711096 113358 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 113358 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
67463039 113115 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322614 113115 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711074 113336 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 113336 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607553 103729 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 103729 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44554515 111439 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
2741913 113564 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 113564 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
67460741 113132 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322630 113132 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
16681707 748 4 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 748 4 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 748 4 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
66575821 113443 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 113443 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
24752558 90865 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 90865 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
118711969 113565 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 113565 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
25175044 126131 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
CHEMBL3652603 126131 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
24985991 191180 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
CHEMBL5197988 191180 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
127041005 136622 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240702 136622 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746901 136622 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747875 136622 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
118711185 113411 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 113411 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
71607634 103728 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 103728 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711077 113339 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 113339 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 536 47 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
127040347 136615 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241743 136615 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747704 136615 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747869 136615 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
11504760 90860 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 90860 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11712235 90890 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 90890 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
44610468 111443 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 111443 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711090 113352 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 113352 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711092 113354 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 113354 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
46241019 136611 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745979 136611 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747865 136611 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751999 62488 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 62488 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751999 62488 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 62488 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751995 62489 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 62489 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968144 164546 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227196 164546 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 113413 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 113413 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
12000767 113108 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322597 113108 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711193 113423 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 113423 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
71264539 103736 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098249 103736 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983672 91663 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 91663 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
118711177 113400 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 113400 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 113417 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113417 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118710245 113152 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 113152 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
74220534 113444 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 113444 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
11532836 90897 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 90897 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987950 164659 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228996 164659 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711071 113333 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 113333 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711249 113449 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 113449 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
145970219 164573 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227595 164573 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145969360 164643 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228736 164643 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
118711064 113327 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113327 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607662 103726 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098236 103726 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44762396 113563 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 113563 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
59534140 113144 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322642 113144 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11706351 90873 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 90873 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
71607589 103724 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 103724 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11993787 91666 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 91666 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
24751708 62517 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 62517 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711064 113327 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113327 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463112 113112 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322611 113112 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
71607592 103727 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 103727 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
71607664 103732 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098243 103732 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
44762396 113563 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 113563 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
67460401 113116 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322615 113116 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68600802 126134 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652606 126134 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
15983546 91673 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 91673 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
66575899 113442 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 113442 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
118711970 113566 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326903 113566 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
66575899 113442 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
CHEMBL3325891 113442 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
44296486 188354 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL50806 188354 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL540200 193200 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
11684912 90870 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 90870 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
23642329 62491 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 62491 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711075 113337 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 113337 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711098 113361 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 113361 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 113410 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 113410 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
24752560 62475 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 62475 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 62493 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 62493 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 62516 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 62516 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145967823 164405 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4225138 164405 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
71607553 103729 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 103729 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67462688 113114 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322613 113114 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12002005 113125 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322624 113125 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
1776 775 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
5006 775 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
9854012 775 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
CHEMBL334966 775 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
DB06441 775 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
11561528 90892 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 90892 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL300240 101347 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 652 9 2 14 3.0 CCOC(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C(=O)OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711076 113338 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 113338 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66575818 113570 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 113570 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
69224555 91660 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 91660 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
24751572 62226 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 62226 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
24752269 62472 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 62472 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752559 62478 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 62478 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
10292521 164423 7 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225415 164423 7 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
22184925 164592 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
CHEMBL4227910 164592 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
6918456 14348 107 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
CHEMBL1201772 14348 107 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
118711973 113569 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 113569 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145970653 164541 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227170 164541 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607633 103725 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098235 103725 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11569565 90889 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 90889 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711174 113397 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 113397 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 113398 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 113398 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11503160 90882 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 90882 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11503687 90898 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 90898 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913927 90887 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 90887 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24750723 62484 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 62484 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750557 62485 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 62485 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145967657 164511 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226648 164511 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
24752128 62474 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 62474 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750719 62524 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 62524 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145970872 164516 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226722 164516 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
15983670 91657 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 91657 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
118711073 113335 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 113335 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607666 103734 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 103734 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67459391 113117 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322616 113117 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24786234 139217 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 139217 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1776 775 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
5006 775 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
9854012 775 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
CHEMBL334966 775 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
DB06441 775 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
24786234 139217 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 139217 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1756 459 8 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5310954 459 8 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL336292 459 8 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
87416471 191073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5196387 191073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
73603967 113445 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 113445 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
15982393 90891 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 90891 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576297 113360 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 113360 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711190 113418 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113418 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113420 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113420 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113421 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11620159 91670 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 91670 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
11697626 91672 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 91672 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
145970444 164596 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227949 164596 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711185 113411 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 113411 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
90644282 111438 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 111438 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711972 113568 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 113568 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67462328 113120 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322619 113120 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461716 113129 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322628 113129 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001755 113143 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322641 113143 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68913927 90887 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 90887 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
127039361 136618 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
127039919 136618 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746192 136618 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747871 136618 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11699088 90856 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 90856 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752130 62477 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 62477 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145969883 164390 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4224920 164390 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
54697995 193057 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL53491 193057 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
145986354 164684 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229217 164684 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
12002012 113148 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322646 113148 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67464394 113124 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322623 113124 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
23649325 536 47 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
66576377 113404 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113404 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
71607631 103730 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 103730 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
127039316 136614 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46196450 136614 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747385 136614 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747868 136614 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
69223141 91653 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419480 91653 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
118711067 113331 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113331 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
44296002 14618 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206713 14618 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299307 14618 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
168274164 189815 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5177774 189815 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL301991 101586 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 536 5 2 10 3.3 Cc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
145969318 164584 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227756 164584 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
67463698 113138 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322636 113138 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 111439 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118710244 113151 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322649 113151 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11570029 90875 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 90875 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
73294137 91661 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 91661 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
118711183 113409 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 113409 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
24751438 62473 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 62473 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751300 62483 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 62483 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11451 3162 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
132574707 3162 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
CHEMBL4116316 3162 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
118711972 113568 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 113568 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911027 90854 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 90854 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
24751850 62492 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 62492 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983546 91673 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 91673 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
127040000 136612 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241331 136612 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746558 136612 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747866 136612 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
73345971 90868 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 90868 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
24751017 90896 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 90896 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751581 62189 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 62189 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54580185 62230 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 62230 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
60606 61231 68 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
CHEMBL1771 61231 68 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
137630000 160483 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4087247 160483 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116405 160483 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
67460268 113145 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322643 113145 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627571 90859 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 90859 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145970953 164625 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228415 164625 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711972 113568 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 113568 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67461519 113119 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322618 113119 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 90885 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 90885 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576450 113396 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 113396 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11526078 90876 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 90876 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987961 164688 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229257 164688 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711249 113449 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 113449 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
12000848 113109 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322598 113109 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 90885 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 90885 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576298 113321 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113321 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711102 113366 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 113366 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459575 113123 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322622 113123 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
145971125 164525 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226913 164525 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 113413 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 113413 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
24968874 91667 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 91667 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
54580993 62470 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 62470 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580995 62487 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 62487 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 62515 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 62515 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711065 113328 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
CHEMBL3325626 113328 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
66575821 113443 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 113443 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
67464143 113118 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322617 113118 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461890 113137 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322635 113137 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68598655 126137 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652609 126137 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711173 113395 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 113395 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607589 103724 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 103724 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983053 91658 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 91658 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
68556549 111437 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 111437 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711098 113361 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 113361 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
16681707 748 4 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 748 4 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 748 4 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
71607631 103730 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 103730 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
15983672 91663 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 91663 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
69224054 91665 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 91665 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
68913220 90853 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 90853 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
118710243 113147 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322645 113147 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
137630586 160540 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4081274 160540 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116838 160540 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
25022583 126144 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
CHEMBL3652616 126144 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
25022583 126144 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
CHEMBL3652616 126144 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
59534139 113154 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322652 113154 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44464779 113155 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 113155 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
42629406 190576 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5188874 190576 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
69224988 91664 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 91664 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
25110832 189370 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5170672 189370 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
66576297 113360 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 113360 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576451 113405 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113405 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 113419 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113419 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113421 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 120062 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120062 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120062 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 113417 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113417 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711190 113418 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113418 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113420 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113420 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113421 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11503687 90898 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 90898 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711974 113571 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326908 113571 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 90850 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 90850 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11677907 90852 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 90852 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
118711067 113331 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113331 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 120063 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120063 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120063 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001296 113133 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322631 113133 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
46241233 136613 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746620 136613 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747867 136613 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
2746550 62480 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 62480 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
127040676 136619 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240598 136619 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746188 136619 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747872 136619 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751297 62486 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 62486 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
22916 14556 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL1206272 14556 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL256057 14556 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
71607687 103738 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098251 103738 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983670 91657 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 91657 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
11547134 191929 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
CHEMBL5209548 191929 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
2746549 62223 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 62223 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 62509 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 62509 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 3757 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
4184 3757 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
9871419 3757 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
CHEMBL398435 3757 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
DB08816 3757 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
23649325 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
23649325 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24751579 62490 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 62490 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15982393 90891 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 90891 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711094 113356 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 113356 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607689 103735 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 103735 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
2746549 62223 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 62223 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24752131 62512 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 62512 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 113446 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 113446 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 113422 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 113422 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 113408 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113408 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
168293684 191594 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5204363 191594 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
127040999 136621 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240799 136621 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746598 136621 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747874 136621 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
12001662 113150 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322648 113150 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607632 103731 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 103731 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
118711066 113330 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113330 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54732977 101307 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL299983 101307 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
54732982 101416 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL300750 101416 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
137630492 160530 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4090874 160530 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4116755 160530 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
67460935 113128 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322627 113128 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11691323 90879 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 90879 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711186 113412 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 113412 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
54732979 187822 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL50192 187822 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
66919972 189489 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5172707 189489 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
11519648 90869 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 90869 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24751712 62500 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 62500 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68916097 90862 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 90862 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
68911205 91671 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 91671 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
68911205 91671 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 91671 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
66576448 120062 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120062 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120062 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
118710245 113152 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 113152 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68597944 126142 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652614 126142 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68601276 126147 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652619 126147 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
44554515 111439 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
44464779 113155 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 113155 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11569565 90889 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 90889 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL540200 193200 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Compound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyteCompound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyte
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
74220534 113444 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 113444 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
67462098 113149 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322647 113149 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66576298 113321 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113321 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711083 113345 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 113345 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711093 113355 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 113355 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711097 113359 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 113359 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711101 113364 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 113364 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711102 113366 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 113366 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711172 113394 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 113394 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711174 113397 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 113397 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711180 113403 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 113403 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 113406 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113406 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576610 113407 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113407 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
66576296 113417 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113417 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113421 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576221 113447 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 113447 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
66575819 113329 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113329 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 113404 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113404 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
118711191 113419 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113419 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711073 113335 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 113335 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711973 113569 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 113569 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 111439 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711097 113359 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 113359 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607665 103737 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 103737 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711066 113330 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113330 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54584163 62227 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 62227 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
1765 3757 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
4184 3757 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
9871419 3757 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
CHEMBL398435 3757 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
DB08816 3757 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
11569565 90889 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 90889 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
68916097 90862 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 90862 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
12001028 113030 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3321766 113030 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118710246 113153 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322651 113153 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11663657 90871 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 90871 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68914580 90881 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 90881 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24750876 62510 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 62510 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145970029 164622 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4228398 164622 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
23649325 536 47 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118711099 113362 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 113362 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983301 90884 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 90884 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68916926 139161 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 139161 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
2741913 113564 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 113564 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
145967859 164460 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4225935 164460 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
118711086 113348 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 113348 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 113365 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 113365 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118710241 113121 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322620 113121 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67459247 113142 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322640 113142 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66575819 113329 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113329 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
54579997 62519 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 62519 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711078 113340 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 113340 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711971 113567 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
CHEMBL3326904 113567 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
53233471 62508 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 62508 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
53233471 62508 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 62508 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
66576451 113405 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113405 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711181 113406 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113406 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576221 113447 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 113447 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
71607632 103731 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 103731 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11561748 91668 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 91668 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
44296000 14622 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206719 14622 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299895 14622 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
24752421 62511 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 62511 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 113446 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 113446 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
168283736 192301 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5183695 192301 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5222086 192301 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
68911008 90886 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 90886 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
71607665 103737 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 103737 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
24752557 62476 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 62476 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598694 126140 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652612 126140 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
68599106 126143 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652615 126143 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68599934 126145 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
CHEMBL3652617 126145 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
1765 3757 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
4184 3757 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
9871419 3757 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
CHEMBL398435 3757 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
DB08816 3757 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
66575819 113329 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113329 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
127047545 139046 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 139046 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
66576610 113407 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113407 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
16066663 77789 32 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
CHEMBL2103828 77789 32 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
118711085 113347 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 113347 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711089 113351 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 113351 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 113398 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 113398 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711177 113400 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 113400 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711178 113401 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 113401 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 113404 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113404 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
66576375 120063 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120063 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120063 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576298 113321 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113321 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576451 113405 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113405 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 113408 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113408 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113421 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 120062 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120062 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120062 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 120063 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120063 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120063 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
1765 3757 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
4184 3757 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
9871419 3757 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
CHEMBL398435 3757 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
DB08816 3757 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
11561748 91668 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 91668 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
24752271 62503 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 62503 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752270 62504 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 62504 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 3757 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
4184 3757 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
9871419 3757 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
CHEMBL398435 3757 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
DB08816 3757 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
67460979 113127 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322626 113127 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67463220 113141 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322639 113141 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11656053 90878 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 90878 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184858 164447 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4225733 164447 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
12001567 113130 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322629 113130 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001030 113136 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322634 113136 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711188 113414 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325799 113414 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
54583974 62497 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 62497 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711250 113450 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 113450 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
67462183 113139 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322637 113139 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627317 90861 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 90861 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54584960 62525 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 62525 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54585885 62501 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 62501 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711194 113424 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 113424 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
24752561 62502 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 62502 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68910943 91669 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 91669 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
67462816 113126 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322625 113126 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24750874 62513 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 62513 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
118711189 113416 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325800 113416 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
69224555 91660 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 91660 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68911289 90880 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL2402255 90880 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL5206028 90880 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
68911289 90880 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 90880 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 90880 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
66575899 113442 2 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 113442 2 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
68910943 91669 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 91669 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
137630841 160566 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4069492 160566 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4117118 160566 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
118711081 113343 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 113343 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711182 113408 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113408 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 113422 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 113422 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
24751998 62495 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 62495 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751851 62494 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 62494 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751998 62495 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 62495 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711070 113332 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 113332 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711075 113337 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 113337 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11949423 191777 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207480 191777 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
24750561 62522 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 62522 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
11503160 90882 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 90882 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68918061 90851 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 90851 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
71607663 103733 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098244 103733 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11677907 90852 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 90852 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
46233355 198865 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL598998 198865 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 111439 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111439 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
68601482 126133 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
CHEMBL3652605 126133 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
118711087 113349 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 113349 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607592 103727 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 103727 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11641496 90855 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 90855 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711095 113357 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 113357 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 113399 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 113399 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71740819 90864 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 90864 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579996 62496 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 62496 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600085 126132 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
CHEMBL3652604 126132 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
15983052 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
68910943 91669 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 91669 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11699570 90874 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 90874 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68842714 90893 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 90893 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579995 62482 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 62482 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11497605 90872 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 90872 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
10294407 164556 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227347 164556 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
69224054 91665 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 91665 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
66576220 113421 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
73603967 113445 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 113445 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
118711973 113569 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 113569 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711179 113402 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 113402 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711094 113356 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 113356 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711100 113363 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 113363 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 113365 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 113365 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711193 113423 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 113423 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576610 113407 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113407 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
44555026 111450 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 111450 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68600647 126136 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652608 126136 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711079 113341 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 113341 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 113344 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 113344 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24937181 195773 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL569732 195773 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
118711088 113350 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 113350 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001479 113135 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322633 113135 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
127038949 136625 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46241636 136625 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746852 136625 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747878 136625 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11620159 91670 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 91670 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
118711248 113448 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 113448 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
24752419 62506 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 62506 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711100 113363 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 113363 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711183 113409 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 113409 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
118710242 113146 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322644 113146 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24752422 62479 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 62479 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44296487 101564 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
CHEMBL301805 101564 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
24751576 62520 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 62520 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11519648 90869 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 90869 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
15983301 90884 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 90884 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
145969559 164602 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228020 164602 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
68599474 126146 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652618 126146 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
66576220 113421 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113421 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
127047545 139046 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 139046 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
118711969 113565 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 113565 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL53599 193072 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 568 7 2 12 2.7 COc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711070 113332 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 113332 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711078 113340 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 113340 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 113344 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 113344 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711099 113362 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 113362 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711173 113395 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 113395 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711067 113331 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113331 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
11699570 90874 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 90874 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
90644281 111446 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 111446 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
118711194 113424 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 113424 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
118711101 113364 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 113364 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24752711 62505 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 62505 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598525 126135 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652607 126135 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711064 113327 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113327 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711080 113342 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 113342 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
22184814 164420 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225388 164420 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607666 103734 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 103734 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
68913141 90883 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 90883 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711178 113401 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 113401 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145967492 164627 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228420 164627 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145986356 164685 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229219 164685 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
145970199 164537 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227070 164537 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711085 113347 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 113347 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11684524 90877 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 90877 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 90888 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 90888 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711076 113338 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 113338 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 62225 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 62225 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
69224603 91654 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 91654 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
118711092 113354 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 113354 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 62225 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 62225 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184796 164620 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4228342 164620 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
23649325 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68598844 126138 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
CHEMBL3652610 126138 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
23649325 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118710247 113156 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322654 113156 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911289 90880 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 90880 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 90880 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11526078 90876 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 90876 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711080 113342 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 113342 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711095 113357 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 113357 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711096 113358 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 113358 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
69224988 91664 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 91664 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
22185105 164585 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4227774 164585 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
118711072 113334 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 113334 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24751574 62224 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 62224 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751574 62224 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 62224 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
118711066 113330 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113330 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711250 113450 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 113450 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
127040997 136620 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240803 136620 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746502 136620 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747873 136620 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
71740705 90863 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 90863 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913141 90883 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 90883 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711071 113333 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 113333 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711084 113346 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 113346 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 90850 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 90850 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706300 90857 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 90857 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711081 113343 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 113343 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459556 113113 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322612 113113 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751996 62521 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 62521 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711248 113448 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 113448 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
54580994 62471 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 62471 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
12000684 113140 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322638 113140 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751710 62518 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 62518 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
66575818 113570 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 113570 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463976 113110 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322599 113110 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
54585098 62229 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 62229 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711186 113412 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 113412 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
71740353 90895 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 90895 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
1756 459 8 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
5310954 459 8 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
CHEMBL336292 459 8 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
168296904 192388 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5199350 192388 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5222620 192388 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
20690446 93983 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL251041 93983 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
58334279 190070 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5181634 190070 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
45485957 195880 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 195880 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485932 195482 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 195482 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485963 195416 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 195416 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232890 199247 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601696 199247 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485958 195447 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 195447 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485931 195190 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 195190 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44443939 93772 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249790 93772 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
46232949 199217 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601489 199217 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485966 195168 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 195168 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485957 195880 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL570295 195880 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485898 195500 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 195500 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485962 195354 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 195354 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485943 195441 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 195441 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485959 195533 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 195533 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232887 199246 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601695 199246 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44129060 81913 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172149 81913 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485961 195330 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 195330 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485965 195097 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 195097 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485968 196070 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 196070 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232894 199249 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601698 199249 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485952 195876 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 195876 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485886 195806 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 195806 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141136 195684 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL569097 195684 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 199243 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601692 199243 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 199243 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601692 199243 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232896 199279 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601903 199279 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485889 195313 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 195313 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485922 195392 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 195392 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 195542 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 195542 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485849 195753 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 195753 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485850 195755 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569680 195755 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 195842 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 195842 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232899 199281 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601905 199281 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485917 195822 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 195822 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 195878 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 195878 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139405 197693 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590950 197693 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139408 199094 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600575 199094 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485938 195849 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 195849 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233241 196864 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578094 196864 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233234 197805 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591712 197805 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232943 199213 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601485 199213 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485915 195846 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 195846 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 195890 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 195890 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44129137 81894 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172129 81894 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233325 196912 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578522 196912 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 197493 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589519 197493 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140552 197952 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592850 197952 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141342 199210 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601478 199210 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 197493 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589519 197493 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232879 197525 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589804 197525 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141342 199210 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601478 199210 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
20690429 96591 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL266922 96591 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485969 195092 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 195092 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485914 195838 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 195838 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140751 197676 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590749 197676 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233243 197881 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592410 197881 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140554 197883 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592441 197883 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232911 197561 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590008 197561 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232950 197582 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590146 197582 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232942 197597 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590260 197597 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232940 199211 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601483 199211 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140553 197958 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592883 197958 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233242 196908 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578507 196908 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 197466 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589335 197466 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 197466 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589335 197466 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
1765 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
4184 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
9871419 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
CHEMBL398435 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
DB08816 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
44443935 153341 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398295 153341 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485944 195122 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565573 195122 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 195278 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 195278 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272861 193810 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 193810 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270323 193577 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551020 193577 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141135 196862 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578076 196862 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139404 197916 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592650 197916 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139592 198734 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598161 198734 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142222 199069 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600370 199069 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141980 199446 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603145 199446 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232921 197591 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590254 197591 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232930 199178 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601274 199178 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485950 195872 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 195872 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
21130371 14718 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1207842 14718 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL445413 14718 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
106250 14747 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
106250 14747 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208092 14747 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208092 14747 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496030 14747 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496030 14747 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25125169 14748 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208096 14748 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496229 14748 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123834 14776 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208284 14776 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522725 14776 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
3018777 59934 5 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1671995 59934 5 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1741070 59934 5 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
44129368 81949 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172270 81949 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129451 81904 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172139 81904 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485887 195251 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566309 195251 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 195463 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 195463 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485930 195518 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 195518 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 195767 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 195767 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 195773 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 195773 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485856 195798 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 195798 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271154 193997 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 193997 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45269438 194327 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 194327 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271154 193997 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556522 193997 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269438 194327 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560009 194327 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233330 196808 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577630 196808 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142218 197517 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589719 197517 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139770 197519 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589737 197519 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140934 197831 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591991 197831 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233240 197880 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592409 197880 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139585 197900 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592535 197900 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139767 197956 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592881 197956 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139951 198531 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596750 198531 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140164 199452 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603151 199452 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232882 197554 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590001 197554 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232927 199176 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601272 199176 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855175 81903 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172138 81903 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45140745 198948 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599422 198948 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
24829943 194240 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 194240 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24829943 194240 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559259 194240 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45267707 194295 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 194295 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233356 198866 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598999 198866 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485848 195711 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 195711 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485863 195789 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 195789 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 195837 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 195837 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485946 196098 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 196098 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 193219 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 193219 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267751 193219 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540672 193219 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141347 196865 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578102 196865 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139407 197449 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589216 197449 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140754 197690 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590874 197690 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141343 198765 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598387 198765 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232920 199203 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601447 199203 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232884 199244 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601693 199244 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232895 199250 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601699 199250 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142448 199997 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL606209 199997 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
11950159 195439 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 195439 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16120270 14775 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208282 14775 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522053 14775 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485864 195311 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 195311 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
3711684 14778 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208290 14778 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524284 14778 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45139955 199447 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603146 199447 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232904 197507 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589597 197507 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232933 197595 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590258 197595 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487796 195280 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566447 195280 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
66854575 81909 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172145 81909 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
46233389 198766 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL598388 198766 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233222 198620 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597380 198620 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44126037 1091 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
5905 1091 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
CHEMBL2172277 1091 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
45485907 195829 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570020 195829 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273819 193483 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 193483 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268593 194937 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564150 194937 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
1765 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
4184 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
9871419 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
CHEMBL398435 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
DB08816 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
45273819 193483 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL550278 193483 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268593 194937 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564150 194937 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140361 197793 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591619 197793 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487821 195442 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 195442 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45267728 194532 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561484 194532 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233388 197497 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL589528 197497 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233630 198870 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599006 198870 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273798 194015 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 194015 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270318 193498 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550415 193498 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485861 195788 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 195788 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193180 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193180 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 193640 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 193640 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268642 193945 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 193945 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 193180 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 193180 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 193181 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539734 193181 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141581 197528 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589817 197528 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140155 198940 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
CHEMBL599399 198940 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
24829442 199568 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603866 199568 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631970 193180 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539733 193180 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45273820 193181 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539734 193181 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232902 197463 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589298 197463 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45270274 194085 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
CHEMBL557553 194085 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
13991590 156824 44 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL4077922 156824 44 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45269482 193124 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538644 193124 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 194681 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 194681 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 194681 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562485 194681 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485858 195646 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 195646 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232923 197564 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590039 197564 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232916 199313 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602110 199313 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487809 195277 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 195277 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45271977 193352 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549307 193352 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233386 198907 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599202 198907 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487841 195128 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 195128 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45485882 195804 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569912 195804 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141770 197669 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590742 197669 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232931 197569 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590087 197569 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25863 59946 53 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1672104 59946 53 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1741102 59946 53 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
11950328 195602 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 195602 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856100 81900 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
CHEMBL2172135 81900 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
71455298 81929 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172166 81929 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11950328 195602 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 195602 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272880 193812 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 193812 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272036 193913 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 193913 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271155 193967 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 193967 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272880 193812 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552973 193812 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272036 193913 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL555342 193913 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271155 193967 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556330 193967 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140162 197792 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591593 197792 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139945 198526 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL596732 198526 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
45139953 199337 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL602294 199337 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232922 197592 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590255 197592 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66854919 81895 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172130 81895 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487838 195633 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 195633 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
66854714 81902 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
CHEMBL2172137 81902 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
45485854 195800 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569908 195800 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123180 14665 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207384 14665 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL401859 14665 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46233668 198561 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL596962 198561 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
45272035 193419 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 193419 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485893 195081 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565249 195081 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485857 195801 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 195801 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11670815 195524 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 195524 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
66856844 81920 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172156 81920 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141776 197962 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592887 197962 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
9953334 93950 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250848 93950 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45271128 193259 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 193259 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25125168 14749 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25125168 14749 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208098 14749 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208098 14749 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496401 14749 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496401 14749 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45487813 195407 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 195407 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44128982 81906 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172142 81906 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45140353 198656 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
CHEMBL597563 198656 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
87791 14756 9 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL1208117 14756 9 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL498229 14756 9 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
45485900 195840 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 195840 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 195870 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 195870 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485953 195888 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 195888 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140551 197950 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592825 197950 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232951 197542 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589901 197542 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232945 199214 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601486 199214 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485936 195378 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 195378 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 195845 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 195845 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141579 197581 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590140 197581 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140938 197716 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591048 197716 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140748 197959 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592884 197959 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631974 199282 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 199282 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485859 195784 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 195784 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 195847 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 195847 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485911 195831 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 195831 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233229 196758 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577236 196758 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140932 197921 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592678 197921 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233329 196984 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579330 196984 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141981 197501 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589554 197501 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139771 199448 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603147 199448 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140928 199648 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604288 199648 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485888 195286 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 195286 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485956 195889 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 195889 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141986 196661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL576331 196661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141134 196838 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577844 196838 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139769 197907 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592577 197907 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232944 197587 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590194 197587 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9823796 153503 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398434 153503 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485908 195835 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 195835 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142445 197671 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590744 197671 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139772 197673 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590746 197673 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142223 199092 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600573 199092 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140365 199451 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603150 199451 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232893 197557 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590004 197557 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232941 199212 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601484 199212 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485896 195104 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 195104 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485933 195848 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 195848 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233233 196863 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578080 196863 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141128 197627 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590418 197627 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485935 195374 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 195374 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485855 195797 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 195797 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233327 196949 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578899 196949 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140558 197701 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590990 197701 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140165 199453 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603152 199453 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232883 197531 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589824 197531 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 199283 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 199283 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232917 199314 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602111 199314 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485918 195299 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 195299 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 195818 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 195818 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855197 81952 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172273 81952 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45269472 194665 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562405 194665 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141582 196897 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578335 196897 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140160 198869 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599005 198869 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66856952 81899 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172134 81899 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487850 195321 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 195321 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45272846 193981 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 193981 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66856999 81901 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172136 81901 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272902 194042 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 194042 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24830601 198970 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599605 198970 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44610760 195634 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 195634 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45269472 194665 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 194665 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25128138 14763 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208159 14763 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL502519 14763 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46232936 199180 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601276 199180 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
39073052 195306 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566661 195306 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
67204 14774 13 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208280 14774 13 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL521709 14774 13 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
45487790 197304 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 197304 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270294 193658 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 193658 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129522 81924 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172160 81924 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485881 195803 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569911 195803 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485901 195843 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 195843 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855285 81928 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172165 81928 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141772 197446 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589198 197446 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141982 197672 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590745 197672 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140936 197740 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591226 197740 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232915 197546 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589930 197546 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232925 197593 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590256 197593 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487789 195481 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 195481 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16066663 77789 32 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
CHEMBL2103828 77789 32 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
45269461 194520 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 194520 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16066663 77789 32 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
CHEMBL2103828 77789 32 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
44128901 81892 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172127 81892 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129058 81897 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172132 81897 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487789 195481 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 195481 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66854417 81922 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172158 81922 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
6689 14745 14 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208089 14745 14 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL495834 14745 14 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
45273818 193179 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 193179 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70683418 73623 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021587 73623 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44583582 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
5904 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
59448166 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL1207916 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL455536 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
45487837 197331 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 197331 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
11955421 197363 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 197363 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
66919940 81955 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172279 81955 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271978 193353 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549308 193353 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271978 193353 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549308 193353 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
167524 14498 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1205665 14498 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL131271 14498 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
66919996 81957 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172280 81957 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44583582 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
5904 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
59448166 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL1207916 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL455536 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
20299057 59942 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1672103 59942 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1741093 59942 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
46233230 197820 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591874 197820 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232886 199245 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601694 199245 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25114519 14777 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208288 14777 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524064 14777 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268619 193834 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 193834 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70687668 73622 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021586 73622 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232932 199179 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601275 199179 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485853 195677 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 195677 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270323 193577 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 193577 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271092 194770 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 194770 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487817 195601 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 195601 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
44129524 81953 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172274 81953 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271092 194770 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563041 194770 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269465 194580 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 194580 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66919958 81959 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172282 81959 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233130 198840 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598821 198840 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268594 193890 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 193890 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233324 197957 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL592882 197957 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45139949 198762 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
CHEMBL598376 198762 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
45139765 198838 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598816 198838 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128387 81943 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172264 81943 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233096 199932 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605847 199932 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485903 195841 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 195841 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271984 193418 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 193418 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
10202847 197346 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585852 197346 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45271984 193418 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549724 193418 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232903 197559 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590006 197559 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487843 195517 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 195517 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487817 195601 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 195601 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
10109037 195438 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567695 195438 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45485934 195301 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 195301 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 196068 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 196068 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 195278 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 195278 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233228 196839 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577854 196839 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139768 197947 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592810 197947 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485967 195868 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 195868 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855732 81912 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172148 81912 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44443933 97834 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL274713 97834 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
46233237 196981 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579289 196981 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 197505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589584 197505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140366 199042 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600055 199042 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 197505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589584 197505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142219 197588 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590208 197588 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140930 197614 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590364 197614 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140937 197741 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591227 197741 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232947 199215 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601487 199215 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485954 195877 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 195877 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193180 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
CHEMBL539733 193180 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
45272869 193811 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552972 193811 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140931 197668 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590741 197668 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232935 197566 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590069 197566 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485960 195450 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 195450 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 195891 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 195891 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233328 196963 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579081 196963 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140557 197684 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590798 197684 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485902 195749 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 195749 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140939 197733 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591185 197733 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139587 197905 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592563 197905 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139950 197908 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592581 197908 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139766 197946 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592806 197946 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272869 193811 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 193811 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45140556 198587 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597150 198587 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232830 197494 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589520 197494 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142221 197460 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589283 197460 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128980 81907 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
CHEMBL2172143 81907 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
44129445 81945 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172266 81945 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45485860 195785 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 195785 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 195561 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 195561 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45487850 195321 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 195321 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45268630 194414 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560748 194414 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139401 199000 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599825 199000 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232937 197596 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590259 197596 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232924 199174 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601270 199174 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233589 198590 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597158 198590 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11649278 14746 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208091 14746 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496022 14746 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268630 194414 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 194414 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
121990 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1710 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1763 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
CHEMBL435402 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
45487837 197331 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 197331 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
45270288 193602 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 193602 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 193602 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551217 193602 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272881 193192 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 193192 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129449 81927 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172163 81927 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272881 193192 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539983 193192 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140156 198942 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599400 198942 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272055 193224 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 193224 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272055 193224 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540737 193224 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485895 195589 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568498 195589 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270296 193659 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 193659 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11955421 197363 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 197363 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45270296 193659 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551620 193659 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273812 194083 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL557535 194083 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271082 193808 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552921 193808 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233355 198865 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598998 198865 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271145 193260 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 193260 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273812 194083 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 194083 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487800 197302 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 197302 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272074 193673 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551750 193673 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233323 199958 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL605964 199958 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
6451084 54677 44 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL1615434 54677 44 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45487843 195517 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 195517 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487841 195128 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 195128 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487809 195277 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 195277 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44125995 81954 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172278 81954 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45267776 194559 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561692 194559 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233322 198971 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599606 198971 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
25124828 14762 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124828 14762 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208131 14762 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208131 14762 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499580 14762 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL499580 14762 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485891 195315 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566753 195315 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45487844 197364 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 197364 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270314 193475 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 193475 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45140746 200025 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL606408 200025 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11955422 195206 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 195206 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
44610760 195634 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 195634 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45141131 197492 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589518 197492 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140929 199252 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601704 199252 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141131 197492 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589518 197492 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232897 197537 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589889 197537 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232881 197548 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589971 197548 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485892 195359 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 195359 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233232 196907 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578482 196907 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485937 195571 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 195571 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139588 197945 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592802 197945 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485947 195869 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 195869 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232891 199248 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601697 199248 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140166 197675 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590748 197675 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485880 195896 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570423 195896 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141987 197458 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589281 197458 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140364 197906 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592570 197906 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140159 197955 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592880 197955 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139406 199070 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600371 199070 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232907 197560 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590007 197560 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139958 197674 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590747 197674 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233235 197851 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592166 197851 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485890 195807 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 195807 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140935 197854 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592195 197854 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232898 199280 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601904 199280 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233326 196892 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578271 196892 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233223 197848 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592163 197848 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232912 199286 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601910 199286 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45272054 193223 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 193223 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
44128981 81908 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172144 81908 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
44129448 81948 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172269 81948 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11955422 195206 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 195206 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
45485865 195688 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569127 195688 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829780 194791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 194791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128900 81896 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172131 81896 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44128468 81921 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172157 81921 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
24829780 194791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563183 194791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233175 198533 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596769 198533 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140157 198796 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598588 198796 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271100 194999 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 194999 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 194999 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564552 194999 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233239 197879 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592408 197879 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139948 198761 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
CHEMBL598375 198761 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
1149185 195516 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568126 195516 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45487842 197306 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 197306 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487813 195407 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 195407 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140750 197826 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591945 197826 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140743 198764 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598386 198764 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140744 198798 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL598594 198798 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45272842 193951 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 193951 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129525 81960 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172284 81960 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487800 197302 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 197302 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140154 198906 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
CHEMBL599197 198906 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
45487844 197364 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 197364 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270322 193114 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 193114 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45139947 198760 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
CHEMBL598374 198760 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
45269483 193125 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 193125 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66855932 81919 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172155 81919 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45270266 193402 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549594 193402 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233354 198996 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599816 198996 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
45267750 194253 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 194253 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267750 194253 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559340 194253 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140158 199959 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605968 199959 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485939 195474 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 195474 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 195561 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 195561 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44129136 81893 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172128 81893 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855902 81914 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
CHEMBL2172150 81914 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
45141129 197661 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590673 197661 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141584 197960 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592885 197960 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232934 197574 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590114 197574 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44443938 93741 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249584 93741 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9850430 93771 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249789 93771 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9846875 93908 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 93908 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 93908 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
18717762 93949 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250847 93949 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45141985 196985 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579334 196985 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485885 195544 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568257 195544 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232914 199311 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602109 199311 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485941 195346 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 195346 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142220 197411 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL588492 197411 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142452 197963 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592888 197963 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139589 199068 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600369 199068 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142451 199095 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600576 199095 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140367 199043 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600056 199043 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142453 197459 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589282 197459 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141580 197608 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590328 197608 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140749 197817 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591839 197817 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232946 197598 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590261 197598 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232926 199175 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601271 199175 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485862 195802 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 195802 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270274 194085 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL557553 194085 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
66854841 81910 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172146 81910 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
46233231 197850 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592165 197850 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141344 198677 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597772 198677 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485905 195844 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 195844 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233236 196964 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579094 196964 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139773 197378 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL586227 197378 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140368 199044 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600057 199044 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485919 195115 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 195115 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139403 197899 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592531 197899 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232913 199310 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602108 199310 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232919 199315 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602112 199315 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
11585281 14761 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208129 14761 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499428 14761 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123181 14751 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1208106 14751 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL496820 14751 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
66856658 81918 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
CHEMBL2172154 81918 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
44631970 193180 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193180 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 193180 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 193180 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
71449929 81944 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172265 81944 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 195170 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 195170 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856790 81916 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
CHEMBL2172152 81916 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
45140927 197500 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589550 197500 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233133 197777 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591510 197777 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25123181 14751 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208106 14751 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496820 14751 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485851 195756 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 195756 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233132 199475 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603333 199475 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66854424 81925 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172161 81925 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855084 81926 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172162 81926 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129447 81947 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172268 81947 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66920261 81958 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172281 81958 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 195170 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 195170 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45141133 196896 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578324 196896 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233224 198973 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599634 198973 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232892 197532 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589828 197532 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139957 199450 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603149 199450 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233225 196790 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577433 196790 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232906 197516 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589697 197516 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232918 197562 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590009 197562 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44631974 199282 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 199282 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9846875 93908 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 93908 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 93908 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
66854759 81898 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172133 81898 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141771 197670 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590743 197670 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141984 197835 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592021 197835 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232888 197539 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589897 197539 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232901 197558 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590005 197558 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 199283 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 199283 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485909 195836 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 195836 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139586 197935 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592737 197935 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139402 198976 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599637 198976 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45270314 193475 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL550206 193475 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
66854409 81923 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172159 81923 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233131 198871 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599020 198871 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25127813 14744 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208083 14744 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL495605 14744 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45142446 198676 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597765 198676 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25124162 59943 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1671994 59943 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1741096 59943 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
25128136 14719 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207855 14719 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL446904 14719 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45273789 194233 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 194233 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45273789 194233 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL559126 194233 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45141130 197462 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589290 197462 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44129446 81946 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172267 81946 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
9969173 196799 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL577508 196799 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
25123183 14767 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
25123183 14767 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL1208235 14767 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL1208235 14767 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL509572 14767 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL509572 14767 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
25124484 14581 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124484 14581 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206415 14581 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206415 14581 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271672 14581 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL271672 14581 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45269454 194444 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 194444 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142449 194656 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 194656 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487821 195442 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 195442 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45269454 194444 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561007 194444 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142449 194656 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562344 194656 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
136677322 3244 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
1739 3244 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
656725 3244 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
CHEMBL1160031 3244 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
45270321 193847 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 193847 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
45139400 198557 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596939 198557 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 193181 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 193181 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 195047 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 195047 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 195047 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564981 195047 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141585 197692 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590939 197692 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485942 195850 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 195850 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232948 199216 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601488 199216 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855824 81951 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172272 81951 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46232928 199177 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601273 199177 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485940 195085 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565300 195085 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485916 195226 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 195226 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139590 199096 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600577 199096 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485913 196113 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571929 196113 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139591 198733 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598160 198733 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232880 197547 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589961 197547 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141583 196929 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578714 196929 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142450 199093 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600574 199093 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
5906 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
66855377 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
CHEMBL2172140 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
5906 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
66855377 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
CHEMBL2172140 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
44129369 81915 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
CHEMBL2172151 81915 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
45140933 197766 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591427 197766 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139952 198560 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596961 198560 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139956 199449 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603148 199449 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232889 197556 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590003 197556 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485883 195805 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569913 195805 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123505 14753 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL1208113 14753 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL498038 14753 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
44129371 81911 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172147 81911 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
45485852 195748 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 195748 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270267 193425 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549797 193425 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233357 199895 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605565 199895 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
13782419 14582 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206416 14582 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271673 14582 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
11670815 195524 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 195524 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
45273782 193836 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 193836 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273782 193836 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL553654 193836 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487842 197306 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 197306 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487790 197304 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 197304 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45139946 198527 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596733 198527 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
20638786 154423 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL401158 154423 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
11950159 195439 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 195439 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233176 199686 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604497 199686 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232885 197555 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590002 197555 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485948 195887 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570384 195887 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140753 197681 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590771 197681 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232905 197509 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589616 197509 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485945 195402 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 195402 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485951 195874 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570271 195874 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 196067 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 196067 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140752 197689 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590856 197689 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140362 197760 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591367 197760 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232909 197545 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589927 197545 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233227 197849 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592164 197849 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232908 199284 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601908 199284 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140163 197652 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590602 197652 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140555 197700 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590989 197700 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139954 198939 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599397 198939 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232910 199285 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601909 199285 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45269484 193992 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 193992 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
66857005 81917 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
CHEMBL2172153 81917 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
45270295 193103 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 193103 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128983 81905 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172141 81905 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45487838 195633 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 195633 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
46233095 197737 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL591212 197737 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
46233134 197783 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
CHEMBL591536 197783 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
16681707 748 4 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
1767 748 4 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
CHEMBL2172275 748 4 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
46233451 198706 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597980 198706 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25128135 14750 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208102 14750 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496620 14750 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45140161 197801 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591691 197801 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
168293759 191569 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5203993 191569 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
46233174 199005 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599843 199005 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141773 199445 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603144 199445 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233226 196809 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577653 196809 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233238 197878 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592407 197878 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485921 195343 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 195343 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485894 195777 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 195777 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141345 196792 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577454 196792 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140363 197920 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592671 197920 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141578 197599 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590262 197599 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272861 193810 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552971 193810 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141774 197961 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592886 197961 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232929 197594 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590257 197594 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45267728 194532 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 194532 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268641 193170 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 193170 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142447 198739 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598177 198739 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139764 198799 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL598612 198799 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
45269473 194666 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 194666 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
71462475 81950 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172271 81950 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45267722 194426 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 194426 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 194426 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560882 194426 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
22916 14556 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
22916 14556 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206272 14556 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206272 14556 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL256057 14556 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL256057 14556 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45270300 193726 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 193726 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273811 194822 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 194822 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270300 193726 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552022 193726 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
1756 459 8 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
5310954 459 8 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
CHEMBL336292 459 8 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
60606 61231 68 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
CHEMBL1771 61231 68 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
1765 3757 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 3757 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 3757 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 3757 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 3757 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1765 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
4184 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
9871419 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
CHEMBL398435 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
DB08816 3757 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
1712 285 64 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
6022 285 64 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
CHEMBL14830 285 64 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
44126037 1091 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
5905 1091 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
CHEMBL2172277 1091 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
44583582 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
5904 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
59448166 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL1207916 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL455536 3155 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
1765 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
4184 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
9871419 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
CHEMBL398435 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
DB08816 3757 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
23649325 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
23649325 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
7360 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
7360 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
CHEMBL2419490 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
CHEMBL2419490 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
5906 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
66855377 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
CHEMBL2172140 1009 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
121990 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1710 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1763 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
CHEMBL435402 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
10000627 2967 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
11136 2967 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
1773 2967 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
56947084 2967 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
10066813 942 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474
1772 942 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474